+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Extracorporeal Membrane Oxygenation System global market

Extracorporeal Membrane Oxygenation System global market

Global Extracorporeal Membrane Oxygenation System Market Research Report 2025

This report on the global extracorporeal membrane oxygenation system market research report 2025 offers a comprehensive analysis of market size, growth drivers, emer

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Chem Reports – Global Extracorporeal Membrane Oxygenation (ECMO) System Market Forecast (2025–2035)

Market Prediction
The ECMO System market was valued at USD xxxx units in 2024 and is projected to reach USD xxxx units by 2035, growing at a CAGR of xx% globally.

Global ECMO System Market Overview

The Global Extracorporeal Membrane Oxygenation System Market Report 2020 provides an extensive industry analysis of development components, market patterns, flows, and sizes. It calculates present and historical market values to forecast potential market performance during 2025–2035.

This research study utilized both primary and secondary data sources, examining parameters such as:

  • Government policy and regulatory environment
  • Market dynamics and competitive landscape
  • Historical data and current market trends
  • Technological innovation and upcoming advancements
  • Progress in related industries

Impact of COVID-19 on ECMO System Market

Since the outbreak of COVID-19 in December 2019, the pandemic disrupted global healthcare systems and accelerated demand for advanced respiratory support technologies. The ECMO market was significantly impacted in 2020, with increased adoption in critical care settings for severe respiratory failure cases. This surge highlighted the importance of ECMO systems in emergency preparedness and intensive care.

Global ECMO System Market Segmentation

By Type

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)

By Application

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Regional Analysis

  • North America (U.S., Canada, Mexico): Largest market, driven by advanced healthcare infrastructure, high adoption in ICUs, and strong presence of key players.
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.): Mature market with emphasis on advanced critical care technologies and government support for healthcare innovation.
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.): Fastest-growing region, driven by expanding healthcare facilities, rising incidence of cardiac and respiratory diseases, and government investments.
  • South America (Brazil, Argentina, etc.): Moderate growth supported by healthcare modernization and increasing adoption in tertiary hospitals.
  • Middle East & Africa (Saudi Arabia, South Africa, etc.): Emerging demand driven by investments in healthcare infrastructure and critical care capacity building.

Key Market Players

  • Getinge Group
  • Medtronic plc
  • LivaNova PLC
  • XENIOS AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • NIPRO Corporation
  • OriGen Biomedical Inc.
  • ALung Technologies Inc.
  • EUROSETS S.r.l.

The global ECMO system market—covering veno-arterial (VA), veno-venous (VV), and arterio-venous (AV) configurations—is projected to grow steadily through 2035. Demand is driven by rising incidence of respiratory and cardiac failure, increasing adoption in critical care units, and technological advancements in portable and user-friendly ECMO devices. Growth is tempered by high costs, limited availability of trained personnel, and regulatory hurdles.

Regional Analysis

North America (U.S., Canada, Mexico)

  • Largest market due to advanced healthcare infrastructure and high adoption in ICUs.
  • Strong presence of leading manufacturers (Medtronic, Getinge, LivaNova).
  • Government support for critical care innovation.

Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)

  • Mature market with emphasis on advanced critical care technologies.
  • Stringent regulatory frameworks (EMA, CE Mark) ensure product quality and safety.
  • Stable demand with focus on neonatal and pediatric ECMO applications.

Asia-Pacific (China, India, Japan, Southeast Asia, etc.)

  • Fastest-growing region, driven by expanding healthcare facilities and rising incidence of cardiac/respiratory diseases.
  • Japan and South Korea lead in adoption of advanced ECMO technologies.
  • China and India investing heavily in critical care infrastructure.

South America (Brazil, Argentina, etc.)

  • Moderate growth supported by healthcare modernization and tertiary hospital adoption.
  • Reliance on imports for advanced ECMO systems.

Middle East & Africa (Saudi Arabia, South Africa, etc.)

  • Emerging demand driven by investments in healthcare infrastructure.
  • Heavy reliance on imports; limited local manufacturing capacity.
  • Growth tied to government-backed critical care initiatives.

Detailed Segmentation Analysis

By Type

  • Veno-Arterial (VA): Supports both heart and lung function; widely used in cardiac failure cases.
  • Veno-Venous (VV): Supports lung function only; dominant in respiratory failure treatment.
  • Arterio-Venous (AV): Less common; used in specific clinical scenarios.

By Application

  • Respiratory: Treatment of ARDS, severe pneumonia, and COVID-related complications.
  • Cardiac: Support in cases of cardiogenic shock, heart failure, and post-cardiac surgery.
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR): Emergency use in cardiac arrest cases.

Porter’s Five Forces

  1. Threat of New Entrants: Low – high capital investment, regulatory barriers, and need for clinical expertise.
  2. Bargaining Power of Suppliers: Moderate – reliance on specialized components (oxygenators, pumps, cannulas).
  3. Bargaining Power of Buyers: High – hospitals demand cost-effective, reliable systems with strong after-sales support.
  4. Threat of Substitutes: Low – few alternatives provide comparable life-support capabilities.
  5. Industry Rivalry: High – intense competition among established players with continuous innovation.

SWOT Analysis

Strengths

  • Life-saving technology with proven clinical outcomes.
  • Strong demand in critical care and emergency medicine.
  • Continuous innovation in portable and user-friendly systems.

Weaknesses

  • High cost of equipment and procedures.
  • Limited availability of trained personnel.
  • Complex regulatory approval processes.

Opportunities

  • Rising incidence of respiratory and cardiac diseases.
  • Expansion into emerging markets with growing healthcare infrastructure.
  • Technological advancements in miniaturization and portability.

Threats

  • Stringent regulatory compliance requirements.
  • Competition from alternative critical care technologies.
  • Supply chain disruptions and geopolitical risks.

Trend Analysis

  • COVID-19 Impact: Accelerated adoption of ECMO in respiratory failure cases.
  • Portable ECMO Systems: Increasing demand for mobile and transport-friendly devices.
  • Technological Innovation: Advances in oxygenators, biocompatible materials, and monitoring systems.
  • Training & Education: Growing emphasis on specialized ECMO training programs.
  • Emerging Market Expansion: Rising investments in Asia-Pacific and Middle East healthcare infrastructure.

Drivers & Challenges

Drivers

  • Rising incidence of respiratory and cardiac failure.
  • Increasing adoption in critical care units.
  • Technological advancements in ECMO systems.
  • Government support for healthcare innovation.

Challenges

  • High cost of ECMO procedures and equipment.
  • Limited availability of trained personnel.
  • Complex regulatory approval processes.
  • Ethical concerns regarding prolonged life support.

Value Chain Analysis

  1. Raw Materials & Components: Oxygenators, pumps, cannulas, sensors, and biocompatible materials.
  2. Manufacturing: Assembly of ECMO systems by global medical device companies.
  3. Distribution: Direct sales to hospitals, clinics, and critical care centers.
  4. End-Use Applications: Respiratory failure, cardiac support, and emergency resuscitation.
  5. Regulatory Oversight: Compliance with FDA, EMA, and other international standards.

 

 

1. Market Overview of Extracorporeal Membrane Oxygenation System
    1.1 Extracorporeal Membrane Oxygenation System Market Overview
        1.1.1 Extracorporeal Membrane Oxygenation System Product Scope
        1.1.2 Market Status and Outlook
    1.2 Extracorporeal Membrane Oxygenation System Market Size by Regions:
    1.3 Extracorporeal Membrane Oxygenation System Historic Market Size by Regions
    1.4 Extracorporeal Membrane Oxygenation System Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Extracorporeal Membrane Oxygenation System Sales Market by Type
    2.1 Global Extracorporeal Membrane Oxygenation System Historic Market Size by Type
    2.2 Global Extracorporeal Membrane Oxygenation System Forecasted Market Size by Type
    2.3 Veno-Arterial (VA)
    2.4 Veno-Venous (VV)
    2.5 Arterio-Venous (AV)
3. Covid-19 Impact Extracorporeal Membrane Oxygenation System Sales Market by Application
    3.1 Global Extracorporeal Membrane Oxygenation System Historic Market Size by Application
    3.2 Global Extracorporeal Membrane Oxygenation System Forecasted Market Size by Application
    3.3 Respiratory
    3.4 Cardiac
    3.5 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Extracorporeal Membrane Oxygenation System Production Capacity Market Share by Manufacturers
    4.2 Global Extracorporeal Membrane Oxygenation System Revenue Market Share by Manufacturers
    4.3 Global Extracorporeal Membrane Oxygenation System Average Price by Manufacturers
5. Company Profiles and Key Figures in Extracorporeal Membrane Oxygenation System Business
    5.1 Getinge Group
        5.1.1 Getinge Group Company Profile
        5.1.2 Getinge Group Extracorporeal Membrane Oxygenation System Product Specification
        5.1.3 Getinge Group Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.2 Medtronic plc
        5.2.1 Medtronic plc Company Profile
        5.2.2 Medtronic plc Extracorporeal Membrane Oxygenation System Product Specification
        5.2.3 Medtronic plc Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.3 LivaNova PLC
        5.3.1 LivaNova PLC Company Profile
        5.3.2 LivaNova PLC Extracorporeal Membrane Oxygenation System Product Specification
        5.3.3 LivaNova PLC Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.4 XENIOS AG
        5.4.1 XENIOS AG Company Profile
        5.4.2 XENIOS AG Extracorporeal Membrane Oxygenation System Product Specification
        5.4.3 XENIOS AG Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.5 Terumo Corporation
        5.5.1 Terumo Corporation Company Profile
        5.5.2 Terumo Corporation Extracorporeal Membrane Oxygenation System Product Specification
        5.5.3 Terumo Corporation Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.6 MicroPort Scientific Corporation
        5.6.1 MicroPort Scientific Corporation Company Profile
        5.6.2 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Product Specification
        5.6.3 MicroPort Scientific Corporation Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.7 NIPRO Corporation
        5.7.1 NIPRO Corporation Company Profile
        5.7.2 NIPRO Corporation Extracorporeal Membrane Oxygenation System Product Specification
        5.7.3 NIPRO Corporation Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.8 OriGen Biomedical Inc.
        5.8.1 OriGen Biomedical Inc. Company Profile
        5.8.2 OriGen Biomedical Inc. Extracorporeal Membrane Oxygenation System Product Specification
        5.8.3 OriGen Biomedical Inc. Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.9 ALung Technologies Inc.
        5.9.1 ALung Technologies Inc. Company Profile
        5.9.2 ALung Technologies Inc. Extracorporeal Membrane Oxygenation System Product Specification
        5.9.3 ALung Technologies Inc. Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
    5.10 EUROSETS S.r.l.
        5.10.1 EUROSETS S.r.l. Company Profile
        5.10.2 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Product Specification
        5.10.3 EUROSETS S.r.l. Extracorporeal Membrane Oxygenation System Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Extracorporeal Membrane Oxygenation System Market Size
    6.2 North America Extracorporeal Membrane Oxygenation System Key Players in North America
    6.3 North America Extracorporeal Membrane Oxygenation System Market Size by Type
    6.4 North America Extracorporeal Membrane Oxygenation System Market Size by Application
7. East Asia
    7.1 East Asia Extracorporeal Membrane Oxygenation System Market Size
    7.2 East Asia Extracorporeal Membrane Oxygenation System Key Players in North America
    7.3 East Asia Extracorporeal Membrane Oxygenation System Market Size by Type
    7.4 East Asia Extracorporeal Membrane Oxygenation System Market Size by Application
8. Europe
    8.1 Europe Extracorporeal Membrane Oxygenation System Market Size
    8.2 Europe Extracorporeal Membrane Oxygenation System Key Players in North America
    8.3 Europe Extracorporeal Membrane Oxygenation System Market Size by Type
    8.4 Europe Extracorporeal Membrane Oxygenation System Market Size by Application
9. South Asia
    9.1 South Asia Extracorporeal Membrane Oxygenation System Market Size
    9.2 South Asia Extracorporeal Membrane Oxygenation System Key Players in North America
    9.3 South Asia Extracorporeal Membrane Oxygenation System Market Size by Type
    9.4 South Asia Extracorporeal Membrane Oxygenation System Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Extracorporeal Membrane Oxygenation System Market Size
    10.2 Southeast Asia Extracorporeal Membrane Oxygenation System Key Players in North America
    10.3 Southeast Asia Extracorporeal Membrane Oxygenation System Market Size by Type
    10.4 Southeast Asia Extracorporeal Membrane Oxygenation System Market Size by Application
11. Middle East
    11.1 Middle East Extracorporeal Membrane Oxygenation System Market Size
    11.2 Middle East Extracorporeal Membrane Oxygenation System Key Players in North America
    11.3 Middle East Extracorporeal Membrane Oxygenation System Market Size by Type
    11.4 Middle East Extracorporeal Membrane Oxygenation System Market Size by Application
12. Africa
    12.1 Africa Extracorporeal Membrane Oxygenation System Market Size
    12.2 Africa Extracorporeal Membrane Oxygenation System Key Players in North America
    12.3 Africa Extracorporeal Membrane Oxygenation System Market Size by Type
    12.4 Africa Extracorporeal Membrane Oxygenation System Market Size by Application
13. Oceania
    13.1 Oceania Extracorporeal Membrane Oxygenation System Market Size
    13.2 Oceania Extracorporeal Membrane Oxygenation System Key Players in North America
    13.3 Oceania Extracorporeal Membrane Oxygenation System Market Size by Type
    13.4 Oceania Extracorporeal Membrane Oxygenation System Market Size by Application
14. South America
    14.1 South America Extracorporeal Membrane Oxygenation System Market Size
    14.2 South America Extracorporeal Membrane Oxygenation System Key Players in North America
    14.3 South America Extracorporeal Membrane Oxygenation System Market Size by Type
    14.4 South America Extracorporeal Membrane Oxygenation System Market Size by Application
15. Rest of the World
    15.1 Rest of the World Extracorporeal Membrane Oxygenation System Market Size
    15.2 Rest of the World Extracorporeal Membrane Oxygenation System Key Players in North America
    15.3 Rest of the World Extracorporeal Membrane Oxygenation System Market Size by Type
    15.4 Rest of the World Extracorporeal Membrane Oxygenation System Market Size by Application
16 Extracorporeal Membrane Oxygenation System Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Global ECMO System Market Segmentation

By Type

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)

By Application

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Regional Analysis

  • North America (U.S., Canada, Mexico): Largest market, driven by advanced healthcare infrastructure, high adoption in ICUs, and strong presence of key players.
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.): Mature market with emphasis on advanced critical care technologies and government support for healthcare innovation.
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.): Fastest-growing region, driven by expanding healthcare facilities, rising incidence of cardiac and respiratory diseases, and government investments.
  • South America (Brazil, Argentina, etc.): Moderate growth supported by healthcare modernization and increasing adoption in tertiary hospitals.
  • Middle East & Africa (Saudi Arabia, South Africa, etc.): Emerging demand driven by investments in healthcare infrastructure and critical care capacity building.

Key Market Players

  • Getinge Group
  • Medtronic plc
  • LivaNova PLC
  • XENIOS AG
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • NIPRO Corporation
  • OriGen Biomedical Inc.
  • ALung Technologies Inc.
  • EUROSETS S.r.l.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.